FindTrial
Sign In

Fattening of the Adventitia as MR Imaging basEd biomarker in AAA patients (FAME)

Fattening of the Adventitia as MR Imaging basEd biomarker in AAA patients (FAME) - Fatty Adventitia Mri Evaluation (FAME)

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34591
Enrollment
95
Registered
2011-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dilatation of the abdominal aorta. swelling of the aorta

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Volunteers: >= 18 years Patients: >= 40 years, aneurysm patients (aneurysm is detected with ultrasound)

Exclusion criteria

Exclusion criteria: A known gadolinium allergy, kidney dysfunction with a GFR

Design outcomes

Primary

MeasureTime frame
adventitial fattening of the aortic wall.—

Secondary

MeasureTime frame
The morphological description of the plaque, the number and size of the vaso vasora, the measurements of vascular wall stress, the pulse wave velocity measurements. Aneurysm diameter, aneurysm related complaints, the serum markers of inflammation. Age, length, height, gender, body weight, smoking, diabetes mellitus, cardiovascular risk pattern, family history of aneurysm presence, additional relevant medical history.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)